Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A generous gift from The Sir John Ritblat Family Foundation has enabled the creation of a new Professorship in Mindfulness and Psychological Science. The post, which is to be held by the Director of the Oxford Mindfulness Centre, promises to transform our understanding of the link between mind and body, and lead the world into a new era of human health.

None
A MINDFULNESS-BASED COGNITIVE THERAPY TRAINING SESSION LED BY WILLEM KUYKEN AND MARK WILLIAMS (SHANGHAI, 2018)

Sometimes described as 'the art of conscious living', mindfulness is a natural capacity for moment-by-moment awareness – a practice that enables us to change the way we think and feel about our experiences by developing attentiveness to the present. In recent years, mindfulness has become a recognised form of treatment for both physical and emotional health in mainstream medicine.

Oxford now sits at the forefront of mindfulness research and teaching internationally. Through the Oxford Mindfulness Centre (OMC) – established in 2008 within the Department of Psychiatry – researchers combine ancient wisdom with rigorous contemporary science to better understand the practice's potential for improving health and wellbeing.

The centre's current research agenda has been developed in close collaboration with policy-makers, and the OMC is now undertaking major studies into the promise of mindfulness in education, the workplace and criminal justice systems. The establishment of a permanent post in mindfulness – the first of its kind globally – will enable Oxford to build a permanent research and training centre, and continue to be a leader in this field.

Read more (Oxford Thinking website)

Similar stories

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.